Table 4.
Antifungal susceptibility testing results of four main Candida species against five antifungal drugs.
| Antifungal | C. albicans (N = 40) | C. parapsilosis (N = 37) | C. tropicalis (N = 21) | C. glabrata (N = 9) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S | S-DD | I | R | S | S-DD | I | R | S | S-DD | I | R | S | S-DD | I | R | |
| Anidulafungin | 40 | 0 | 0 | 37 | 0 | 0 | 20 | 0 | 1 | 8 | 0 | 1 | ||||
| Caspofungin | 40 | 0 | 0 | 37 | 0 | 0 | 20 | 1 | 0 | 8 | 0 | 1 | ||||
| Micafungin | 40 | 0 | 0 | 36 | 1 | 0 | 19 | 1 | 1 | 8 | 0 | 1 | ||||
| Fluconazole | 37 | 0 | 3 | 34 | 1 | 2 | 17 | 2 | 2 | 0 | 9 | 0 | 0 | |||
| Voriconazole | 37 | 1 | 2 | 35 | 1 | 1 | 13 | 6 | 2 | |||||||
S, susceptible; SDD, susceptible-dose dependent; I, intermediate; R, resistant.